Impact of Graft-versus-Host Disease on Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Leukemia-Lymphoma Focusing on Preconditioning Regimens: Nationwide Retrospective Study

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 12, 2013, Pages 1731-1739

  Ishida, Takashi ^a   Hishizawa, Masakatsu ^b   Kato, Koji ^c   Tanosaki, Ryuji ^d   Fukuda, Takahiro ^d   Takatsuka, Yoshifusa ^e   Eto, Tetsuya ^f   Miyazaki, Yasushi ^g   Hidaka, Michihiro ^h   Uike, Naokuni ⁱ   Miyamoto, Toshihiro ^c   Tsudo, Mitsuru ^j   Sakamaki, Hisashi ^k   Morishima, Yasuo ^l   Suzuki, Ritsuro ^m   Utsunomiya, Atae ^e  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e IMAMURA BUN IN HOSPITAL   (Japan)

^f HAMANOMACHI HOSPITAL   (Japan)

^g NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

ⁱ NATIONAL KYUSHU CANCER CENTER   (Japan)

^j OSAKA RED CROSS HOSPITAL   (Japan)

^k TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^l AICHI CANCER CENTER HOSPITAL   (Japan)

^m NAGOYA UNIVERSITY   (Japan)

more..

Author keywords

ATL related mortality; HTLV 1; Mogamulizumab; TRM

Indexed keywords

CYCLOSPORIN A; METHOTREXATE;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA REMISSION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; T CELL LEUKEMIA; UMBILICAL CORD BLOOD;

ATL-RELATED MORTALITY; HTLV-1; MOGAMULIZUMAB; TRM;

ACUTE DISEASE; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84887562368     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.09.014     Document Type: Article

References (46)

1. Uchiyama T., Yodoi J., Sagawa K., et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977, 50:481-492.
2. Vose J., Armitage J., Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. JClin Oncol 2008, 26:4124-4130.
3. Tsukasaki K., Hermine O., Bazarbachi A., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. JClin Oncol 2009, 27:453-459.
4. Tsukasaki K., Utsunomiya A., Fukuda H., et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. JClin Oncol 2007, 25:5458-5464.
5. Katsuya H., Yamanaka T., Ishitsuka K., et al. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. JClin Oncol 2012, 30:1635-1640.
6. Bazarbachi A., Plumelle Y., Carlos Ramos J., et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. JClin Oncol 2010, 28:4177-4183.
7. Tsukasaki K., Maeda T., Arimura K., et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999, 23:87-89.
8. Utsunomiya A., Miyazaki Y., Takatsuka Y., et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 27:15-20.
9. Okamura J., Utsunomiya A., Tanosaki R., et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 2005, 105:4143-4145.
10. Fukushima T., Miyazaki Y., Honda S., et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005, 19:829-834.
11. Hishizawa M., Kanda J., Utsunomiya A., et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010, 116:1369-1376.
12. Ishida T., Hishizawa M., Kato K., et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 2012, 120:1734-1741.
13. Iwanaga M., Watanabe T., Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol 2012, 3:322.
14. Harashima N., Kurihara K., Utsunomiya A., et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 2004, 64:391-399.
15. Suzuki S., Masaki A., Ishida T., et al. Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma. Cancer Sci 2012, 103:1764-1773.
16. + T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia 2004, 18:126-132.
17. null mouse model. JImmunol 2013, 191:135-144.
18. Nishikawa H., Maeda Y., Ishida T., et al. Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma. Blood 2012, 119:3097-3104.
19. Choi I., Tanosaki R., Uike N., et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transplant 2011, 46:116-118.
20. Itonaga H., Tsushima H., Taguchi J., et al. Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood 2013, 121:219-225.
21. Kanda J., Hishizawa M., Utsunomiya A., et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 2012, 119:2141-2148.
22. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87). Br J Haematol 1991, 79:428-437.
23. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
24. Sullivan K.M., Agura E., Anasetti C., et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991, 28:250-259.
25. Giralt S., Ballen K., Rizzo D., et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2009, 15:367-369.
26. Bacigalupo A., Ballen K., Rizzo D., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
27. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
28. Anderson J.R., Cain K.C., Gelber R.D. Analysis of survival by tumor response. JClin Oncol 1983, 1:710-719.
29. Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes 2011, 4:363-371.
30. Fine J.P., Gray R.J. Aproportional hazards model for subdistribution of a competing risk. JAm Stat Assoc 1999, 94:496-509.
31. Cortese G., Andersen P. Competing risks and time-dependent covariates. Biomed J 2010, 52:138-158.
32. Flowers M.E., Inamoto Y., Carpenter P.A., et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011, 117:3214-3219.
33. Jagasia M., Arora M., Flowers M.E., et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012, 119:296-307.
34. Arora M., Pidala J., Cutler C.S., et al. Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study. Leukemia 2013, 27:1196-1201.
35. Ozawa S., Nakaseko C., Nishimura M., et al. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Br J Haematol 2007, 137:142-151.
36. Pidala J., Kurland B., Chai X., et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011, 117:4651-4657.
37. Yamamoto K., Utsunomiya A., Tobinai K., et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. JClin Oncol 2010, 28:1591-1598.
38. Ishida T., Joh T., Uike N., et al. Defucosylated anti-CCR4 monoclonalantibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. JClin Oncol 2012, 30:837-842.
39. Ishida T., Ueda R. Antibody therapy for adult T-cell leukemia-lymphoma. Int J Hematol 2011, 94:443-452.
40. Tanosaki R., Tobinai K. Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches. Expert Rev Hematol 2010, 3:743-753.
41. Ito Y., Miyamoto T., Chong Y., et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant 2013, 48:998-999.
42. Ishii T., Ishida T., Utsunomiya A., et al. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma. Clin Cancer Res 2010, 16:1520-1531.
43. Ishida T., Ueda R. Immunopathogenesis of lymphoma: focus on CCR4. Cancer Sci 2011, 102:44-50.
44. Ishida T., Ito A., Sato F., et al. Stevens-Johnson syndrome associated with mogamulizumab treatment of adult T-cell leukemia/lymphoma. Cancer Sci 2013, 104:647-650.
45. + regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood 2007, 110:1689-1697.
46. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005, 11:945-956.